Stephen Inglis

7.6k total citations · 1 hit paper
52 papers, 4.4k citations indexed

About

Stephen Inglis is a scholar working on Epidemiology, Molecular Biology and Genetics. According to data from OpenAlex, Stephen Inglis has authored 52 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 20 papers in Molecular Biology and 17 papers in Genetics. Recurrent topics in Stephen Inglis's work include RNA and protein synthesis mechanisms (16 papers), Influenza Virus Research Studies (13 papers) and Herpesvirus Infections and Treatments (13 papers). Stephen Inglis is often cited by papers focused on RNA and protein synthesis mechanisms (16 papers), Influenza Virus Research Studies (13 papers) and Herpesvirus Infections and Treatments (13 papers). Stephen Inglis collaborates with scholars based in United Kingdom, United States and Australia. Stephen Inglis's co-authors include Ian Brierley, Paul Digard, M. E. G. Boursnell, Ding Xiang Liu, Brian W. J. Mahy, Donald B. Smith, C. M. Brown, Vivian Blok, P Somogyi and M. M. Binns and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Stephen Inglis

51 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of an efficient coronavirus ribosomal frameshifting signal: Requirement for an RNA pseudoknot

1989 555 citations Ian Brierley, Paul Digard et al. profile →

Peers

Countries citing papers authored by Stephen Inglis

Since Specialization

Citations

This map shows the geographic impact of Stephen Inglis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Inglis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Inglis more than expected).

Fields of papers citing papers by Stephen Inglis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Inglis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Inglis. The network helps show where Stephen Inglis may publish in the future.

Co-authorship network of co-authors of Stephen Inglis

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Inglis. A scholar is included among the top collaborators of Stephen Inglis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Inglis. Stephen Inglis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prospects for controlling future pandemics of influenza 2011 ·Virus Research ·James S. Robertson, Stephen Inglis	18
2	Chapter 11: HPV vaccines: Commercial Research & Development 2006 ·Vaccine ·Stephen Inglis, Alan Shaw, Scott Koenig	50
3	Minor Capsid Protein of Human Genital Papillomaviruses Contains Subdominant, Cross-Neutralizing Epitopes 2000 ·Virology ·Richard B.S. Roden, William H. Yutzy, (unknown), Stephen Inglis, Douglas R. Lowy, John T. Schiller	196
4	High-Titer Recombinant Adeno-Associated Virus Production from Replicating Amplicons and Herpes Vectors Deleted for Glycoprotein H 1999 ·Human Gene Therapy ·Xiaoliu Zhang, Mahesh de Alwis, Stephen L. Hart, F.W. Fitzke, Stephen Inglis, M. E. G. Boursnell, Roland J. Levinsky, Christine Kinnon, Robin R. Ali, Adrian J. Thrasher	41
5	Expression of Human Papillomavirus Type 16 L1 Protein inEscherichia coli:Denaturation, Renaturation, and Self-Assembly of Virus-like Particlesin Vitro 1998 ·Virology ·Wei Zhang, (unknown), (unknown), Stephen Inglis, Houman Ashrafian, Margaret Stanley	49
6	An efficient selection system for packaging herpes simplex virus amplicons. 1998 ·Journal of General Virology ·Xiaoliu Zhang, Stephen Inglis, M. E. G. Boursnell, Stacey Efstathiou, Helen O’Shea, Claire Entwisle	20
7	A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 Disease 1997 ·The Journal of Infectious Diseases ·M. E. G. Boursnell, Claire Entwisle, D M Blakeley, Claudia Roberts, Imogen Duncan, Susan E. Chisholm, Gilly Martin, R. Jennings, (unknown), (unknown), Stephen Inglis, C. S. McLean	135
8	A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer 1996 ·The Lancet ·Leszek K. Borysiewicz, Alison Fiander, (unknown), Stephen Man, Gavin W. G. Wilkinson, D. Westmoreland, A. S. Evans, Malcolm Adams, Simon Stacey, M. E. G. Boursnell, Erica Rutherford, Julian Hickling, Stephen Inglis	426
9	Inhibition of the influenza virus RNA-dependent RNA polymerase by antisera directed against the carboxy-terminal region of the PB2 subunit 1996 ·Journal of General Virology ·Vivian Blok, Christopher Cianci, (unknown), Stephen Inglis, Mark Krystal, Paul Digard	38
10	Protective Vaccination Against Primary And Recurrent Disease Caused By Herpes Simplex Virus (HSV) Type 2 Using A Genetically Disabled HSV-1 1994 ·The Journal of Infectious Diseases ·C. S. McLean, Murat Ertürk, R. Jennings, (unknown), A. C. Minson, Imogen Duncan, M. E. G. Boursnell, Stephen Inglis	110
11	Effects of charged amino acid mutations on the bimolecular kinetics of reduction of yeast iso-1-ferricytochrome c by bovine ferrocytochrome b5 1993 ·Biochemistry ·Scott H. Northrup, Kathryn A. Thomasson, (unknown), Paul D. Barker, Lindsay D. Eltis, J. Guy Guillemette, A. Grant Mauk, Stephen Inglis	130
12	Mutational analysis of the “slippery-sequence” component of a coronavirus ribosomal frameshifting signal 1992 ·Journal of Molecular Biology ·Ian Brierley, (unknown), Stephen Inglis	208
13	Identification of two new polypeptides encoded by mRNA5 of the coronavirus infectious bronchitis virus 1992 ·Virology ·Ding Xiang Liu, Stephen Inglis	27
14	Analysis of the invariant Phe82 residue of yeast iso-1-cytochrome c by site-directed mutagenesis using a phagemid yeast shuttle vector 1991 ·Protein Engineering Design and Selection ·Stephen Inglis, J. Guy Guillemette, Jeanette A. Johnson, Michael B. Smith	29
15	A Ribosomal Frameshift Signal in the Polymerase-Encoding Region of the IBV Genome 1990 ·Advances in experimental medicine and biology ·Stephen Inglis, Nicola J. Rolley, Ian Brierley	1
16	Products of the Polymerase-Encoding Region of the Coronavirus IBV 1990 ·Advances in experimental medicine and biology ·Ian Brierley, M. E. G. Boursnell, M. M. Binns, (unknown), Nicola J. Rolley, T. D. K. Brown, Stephen Inglis	9
17	Complex formation between influenza virus polymerase proteins expressed in Xenopus oocytes 1989 ·Virology ·Paul Digard, Vivian Blok, Stephen Inglis	67
18	Identification of a New Gene Product Encoded by mRNA D of Infectious Bronchitis Virus 1987 ·Advances in experimental medicine and biology ·A. R. Smith, M. E. G. Boursnell, M. M. Binns, T. D. K. Brown, Stephen Inglis	6
19	The Mutation Rate and Variability of Eukaryotic Viruses: An Analytical Review 1987 ·Journal of General Virology ·Donald B. Smith, Stephen Inglis	121
20	An influenza virus gene encoding two different proteins 1980 ·Philosophical transactions of the Royal Society of London. Series B, Biological sciences ·Stephen Inglis, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact